Identifying Cancer Cachexia Using Clinical Reasoning AI – ASCO 2026

Press Release: Pangaea Expands its AI Platform to Support Decision-Making & Guideline-Concordance for MDT Tumor Boards Across Enterprise & Community Care

Microsoft & NVIDIA Documentary: Pangaea Data Closing Care Gaps

GO BACK

Pangaea Data is Attending the HIMSS Global Health Conference 2026

March 9th - 12th 2026, Las Vegas, NV, USA

Meet us to learn how Pangaea’s AI platform closes care gaps across hard-to-diagnose conditions based on clinical guidelines. Seamlessly integrated into existing EHR systems and workflows, the platform flags patients who would otherwise be untreated or under-treated despite information in their records. This is helping to improve patient outcomes through multiple clinical purposes at the point of care and for population health, optimizing MDTs (tumor boards) and matching patients for clinical trials, while reducing costs (through early diagnosis and improved triaging) and increasing revenues (through improved prior authorizations and treatments) in a sustainable and compliant manner. The platform is now scaling across 14 countries. 

Please let us know if you are available to meet by registering through the form below or emailing us at info@pangaeadata.ai

Register to Meet Us

Attendees

Vibhor Gupta, PhD
Founder & CEO,
Pangaea Data